Even though LRRK2 loss of function has not been reported to be associated with PD [80], the relevance of these results must not be undermined as LRRK2 inhibitors are being tested in the clinic and it is important to learn about potential side effects, both in the periphery and at central level. Here, LRRK2 is linked to Parkinson disease.